Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P27
Within normal range
vs 3Y Ago
-2.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -15.95% |
| 2023 | -4.33% |
| 2022 | -5.85% |
| 2021 | 6.40% |
| 2020 | -27.91% |
| 2019 | -30.02% |
| 2018 | 21.93% |
| 2017 | -1.68% |
| 2016 | -15.00% |
| 2015 | -25.46% |